AU6497799A - Methods and compositions to induce antitumor response - Google Patents

Methods and compositions to induce antitumor response

Info

Publication number
AU6497799A
AU6497799A AU64977/99A AU6497799A AU6497799A AU 6497799 A AU6497799 A AU 6497799A AU 64977/99 A AU64977/99 A AU 64977/99A AU 6497799 A AU6497799 A AU 6497799A AU 6497799 A AU6497799 A AU 6497799A
Authority
AU
Australia
Prior art keywords
compositions
methods
antitumor response
induce antitumor
induce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64977/99A
Inventor
Drake M. Laface
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canji Inc
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of AU6497799A publication Critical patent/AU6497799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU64977/99A 1998-10-15 1999-10-14 Methods and compositions to induce antitumor response Abandoned AU6497799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17320398A 1998-10-15 1998-10-15
US09173203 1998-10-15
PCT/US1999/021454 WO2000022124A2 (en) 1998-10-15 1999-10-14 Methods and compositions to induce antitumor response

Publications (1)

Publication Number Publication Date
AU6497799A true AU6497799A (en) 2000-05-01

Family

ID=22630966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64977/99A Abandoned AU6497799A (en) 1998-10-15 1999-10-14 Methods and compositions to induce antitumor response

Country Status (2)

Country Link
AU (1) AU6497799A (en)
WO (1) WO2000022124A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229621B2 (en) 1998-10-20 2007-06-12 Torrey Pines Institute For Molecular Studies Method to enhance the immunogenicity of an antigen
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
WO2002040044A2 (en) * 2000-11-17 2002-05-23 Immunex Corporation Chemoattractant recruitment of dendritic cells for enhancement of immunization
CA2439185A1 (en) 2001-02-23 2002-09-06 Novartis Ag Vector constructs
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US9943568B2 (en) 2013-04-18 2018-04-17 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating cancer
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846945A (en) * 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
RU2162342C2 (en) * 1993-10-25 2001-01-27 Кэнджи Инк. Recombinant adenoviral vector and methods of its using
AU4907797A (en) * 1996-10-10 1998-05-05 Wistar Institute Of Anatomy And Biology, The Methods and compositions for inducing a protective immune response to cancers
CN1213401A (en) * 1996-11-15 1999-04-07 先进研究及技术学会 Exodus chemokine materials and method
ES2234040T3 (en) * 1996-11-15 2005-06-16 Canji, Inc. SPECIFIC EXPRESSION OF RETINOBLASTOMA PROTEIN TISSUE.
WO1998039464A2 (en) * 1997-03-03 1998-09-11 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
EP1071459A4 (en) * 1998-03-20 2002-07-17 Genzyme Corp Methods to provoke anti-cancer immune responses

Also Published As

Publication number Publication date
WO2000022124A2 (en) 2000-04-20
WO2000022124A3 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU3671099A (en) Methods and compositions pertaining to pd-loops
AU2846699A (en) Improvements in or relating to enclosures
AUPQ419099A0 (en) Novel compositions and methods
AU3067399A (en) Oxygen-scavenging compositions and articles
AU3731400A (en) Methods and compositions useful in inhibiting apoptosis
AU2349399A (en) R-lansoprazole compositions and methods
AU4215399A (en) Dermatological compositions and methods
EP1056457A4 (en) S-lansoprazole compositions and methods
AU4057197A (en) Composition to aid in the forming of metal
AU9301998A (en) Composition and methods using galectin-1
AU4530299A (en) Dietary manipulation to increase fertility
EP1073333A4 (en) S-rabeprazole compositions and methods
AU7474100A (en) Methods and compositions for reducing immune response
AU5491998A (en) Improvements in or relating to organic compositions
AUPP135598A0 (en) Improvements in or relating to comminution devices
AU6497799A (en) Methods and compositions to induce antitumor response
EP1139981A4 (en) Compositions and methods of using the same
AUPP200698A0 (en) Improvements in or relating to decorative panels
AU3000599A (en) Moisturizing compositions
AU6217199A (en) Compositions
AU7358098A (en) Radioisotope concentrator methods and compositions
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods
EP1073332A4 (en) R-rabeprazole compositions and methods
AU6509899A (en) Odor-control methods and compositions
AU2164400A (en) Flint compositions and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase